Endothelial to mesenchymal cell transition in diabetic retinopathy: targets and therapeutics
Diabetic retinopathy (DR) is a result of neurovacular insults from hyperglycemia in diabetes mellitus (DM), and it is one of the top causes of vision loss throughout the modern world. This review article explores the role endothelial to mesenchymal transition (EndMT) has on the pathogenesis of DR. E...
Main Authors: | Wasef Nijim, Mohamed Moustafa, Julia Humble, Mohamed Al-Shabrawey |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Ophthalmology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fopht.2023.1230581/full |
Similar Items
-
Bone Morphogenetic Proteins and Diabetic Retinopathy
by: Khaled Elmasry, et al.
Published: (2021-04-01) -
Bone Morphogenetic Protein-4 Impairs Retinal Endothelial Cell Barrier, a Potential Role in Diabetic Retinopathy
by: Noureldien H. E. Darwish, et al.
Published: (2023-04-01) -
Indian Diabetic Retinopathy Image Dataset (IDRiD): A Database for Diabetic Retinopathy Screening Research
by: Prasanna Porwal, et al.
Published: (2018-07-01) -
Eicosanoids and Oxidative Stress in Diabetic Retinopathy
by: Mong-Heng Wang, et al.
Published: (2020-06-01) -
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
by: Ines P. Marques, et al.
Published: (2020-05-01)